FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4380995008> ?p ?o ?g. }

• W4380995008 endingPage "3183" @default.
• W4380995008 startingPage "3183" @default.
• W4380995008 abstract "Increasing evidence argues for the promotion of tumorigenesis through activation of the renin-angiotensin system pathway. Accordingly, a benefit of renin-angiotensin system blockers (RABs) treatments has been suggested in patients with solid cancers in terms of survival. We aimed to evaluate in-ICU survival and one-year survival in cancer patients admitted to the ICU with respect to the use of RABs. We conducted a retrospective observational single-center study in a 24-bed medical ICU. We included all solid cancer patients (age ≥ 18 years) requiring unplanned ICU admission. From 2007 to 2020, 1845 patients with solid malignancies were admitted (median age 67 years (59–75), males 61.7%). The most frequent primary tumor sites were the gastrointestinal tract (26.8%), the lung (24.7%), the urological tract (20.1%), and gynecologic and breast cancers (13.9%). RABs were used in 414 patients, distributed into 220 (53.1%) with angiotensin-receptor blockers (ARBs) and 194 (46.9%) with angiotensin-converting enzyme inhibitors (ACEis). After multivariate adjustment, ARBs use (OR = 0.62, 95%CI (0.40–0.92), p = 0.03) and ACEis use (OR = 0.52, 95%CI (0.32–0.82), p = 0.006) were both associated with improved in-ICU survival. Treatment with ARBs was independently associated with decreased one-year mortality (OR = 0.6, 95%CI (0.4–0.9), p = 0.02), whereas treatment with ACEis was not. In conclusion, this study argues for a beneficial impact of RABs use on the prognosis of critically ill cancer patients." @default.
• W4380995008 created "2023-06-17" @default.
• W4380995008 creator A5023519483 @default.
• W4380995008 creator A5049019312 @default.
• W4380995008 creator A5062361877 @default.
• W4380995008 creator A5069387998 @default.
• W4380995008 creator A5083208446 @default.
• W4380995008 creator A5088687424 @default.
• W4380995008 creator A5092189692 @default.
• W4380995008 date "2023-06-14" @default.
• W4380995008 modified "2023-09-30" @default.
• W4380995008 title "Survival Benefit of Renin-Angiotensin System Blockers in Critically Ill Cancer Patients: A Retrospective Study" @default.
• W4380995008 cites W1866290354 @default.
• W4380995008 cites W1898928487 @default.
• W4380995008 cites W1967883762 @default.
• W4380995008 cites W1977202406 @default.
• W4380995008 cites W1997468904 @default.
• W4380995008 cites W2058184342 @default.
• W4380995008 cites W2128349740 @default.
• W4380995008 cites W2149016579 @default.
• W4380995008 cites W2166190627 @default.
• W4380995008 cites W2298838354 @default.
• W4380995008 cites W2302477949 @default.
• W4380995008 cites W2398842590 @default.
• W4380995008 cites W2408718111 @default.
• W4380995008 cites W2623209858 @default.
• W4380995008 cites W2795801698 @default.
• W4380995008 cites W2803977650 @default.
• W4380995008 cites W2895759303 @default.
• W4380995008 cites W2909932177 @default.
• W4380995008 cites W2913873288 @default.
• W4380995008 cites W2935605275 @default.
• W4380995008 cites W2945495989 @default.
• W4380995008 cites W2948656647 @default.
• W4380995008 cites W2953972478 @default.
• W4380995008 cites W2957753965 @default.
• W4380995008 cites W2971618971 @default.
• W4380995008 cites W2973224397 @default.
• W4380995008 cites W2994913654 @default.
• W4380995008 cites W3005984133 @default.
• W4380995008 cites W3008395887 @default.
• W4380995008 cites W3023529892 @default.
• W4380995008 cites W3032054170 @default.
• W4380995008 cites W3086341620 @default.
• W4380995008 cites W3178389255 @default.
• W4380995008 cites W3215487608 @default.
• W4380995008 cites W4200455628 @default.
• W4380995008 cites W4206464823 @default.
• W4380995008 cites W4206841660 @default.
• W4380995008 cites W4247943214 @default.
• W4380995008 cites W4306411832 @default.
• W4380995008 doi "https://doi.org/10.3390/cancers15123183" @default.
• W4380995008 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37370793" @default.
• W4380995008 hasPublicationYear "2023" @default.
• W4380995008 type Work @default.
• W4380995008 citedByCount "0" @default.
• W4380995008 crossrefType "journal-article" @default.
• W4380995008 hasAuthorship W4380995008A5023519483 @default.
• W4380995008 hasAuthorship W4380995008A5049019312 @default.
• W4380995008 hasAuthorship W4380995008A5062361877 @default.
• W4380995008 hasAuthorship W4380995008A5069387998 @default.
• W4380995008 hasAuthorship W4380995008A5083208446 @default.
• W4380995008 hasAuthorship W4380995008A5088687424 @default.
• W4380995008 hasAuthorship W4380995008A5092189692 @default.
• W4380995008 hasBestOaLocation W43809950081 @default.
• W4380995008 hasConcept C121608353 @default.
• W4380995008 hasConcept C126322002 @default.
• W4380995008 hasConcept C143998085 @default.
• W4380995008 hasConcept C167135981 @default.
• W4380995008 hasConcept C170493617 @default.
• W4380995008 hasConcept C198710026 @default.
• W4380995008 hasConcept C2776256026 @default.
• W4380995008 hasConcept C2908929049 @default.
• W4380995008 hasConcept C71924100 @default.
• W4380995008 hasConcept C84393581 @default.
• W4380995008 hasConceptScore W4380995008C121608353 @default.
• W4380995008 hasConceptScore W4380995008C126322002 @default.
• W4380995008 hasConceptScore W4380995008C143998085 @default.
• W4380995008 hasConceptScore W4380995008C167135981 @default.
• W4380995008 hasConceptScore W4380995008C170493617 @default.
• W4380995008 hasConceptScore W4380995008C198710026 @default.
• W4380995008 hasConceptScore W4380995008C2776256026 @default.
• W4380995008 hasConceptScore W4380995008C2908929049 @default.
• W4380995008 hasConceptScore W4380995008C71924100 @default.
• W4380995008 hasConceptScore W4380995008C84393581 @default.
• W4380995008 hasIssue "12" @default.
• W4380995008 hasLocation W43809950081 @default.
• W4380995008 hasLocation W43809950082 @default.
• W4380995008 hasLocation W43809950083 @default.
• W4380995008 hasOpenAccess W4380995008 @default.
• W4380995008 hasPrimaryLocation W43809950081 @default.
• W4380995008 hasRelatedWork W1989591433 @default.
• W4380995008 hasRelatedWork W2008559461 @default.
• W4380995008 hasRelatedWork W2033713032 @default.
• W4380995008 hasRelatedWork W2042660006 @default.
• W4380995008 hasRelatedWork W2126797993 @default.
• W4380995008 hasRelatedWork W2149410839 @default.
• W4380995008 hasRelatedWork W2151139437 @default.

• next